DescriptionLiterature has shown that prescribers receive little education on the treatment of pain resulting in less effective pain treatment with worse outcomes. Attendees will learn the evidence-based analysis of the relative effectiveness of medications and their side effects, recommendations on how to improve treatment of acute and chronic pain and recognizing substance use/opioid use disorders. This program will include the three required topics outlined by the new CME requirement in 21 NCAC 32R .0101:
• Controlled substances prescribing practices
• Recognizing signs of the abuse or misuse of controlled substances
• Controlled substance prescribing for chronic pain management
As of July 1, 2017 all physicians (other than residents), physician assistants, nurse practitioners, podiatrists, and dentists who prescribe controlled substances must satisfy the controlled-substance prescribing CME requirement set forth in 21 NCAC 32R .0101. Requirements vary by discipline and board. Prescribers will turn in controlled substance CME when they renew licensure.
To register for this course please follow a link below:
January 25, 2018 at MAHEC Education Building
February 20, 2018 at McDowell Technical College
May 10, 2018 at MAHEC Education Building
The program is recommended for physicians, physician assistants, pharmacists, nurse practitioners, and podiatrists.
- Describe the impact of the opioid crisis
- Identify the CDC guidelines for prescribing opioids for acute pain
- Identify the CDC guidelines for prescribing opioids for chronic pain
- Discuss what to do with patients on opioids that fall outside the guidelines